$688 Million Settlement Approved in Merck Case By ROSE BOUBOUSHIAN (CN) – Merck and Schering-Plough must pay $688 million for lying to shareholders about the benefits of cholesterol drug Vytorin over its cheaper, generic version, a federal judge ruled. The… Read More ›
Merck & Co
HPV vaccine issues trigger health notice: Japan has issued a nationwide notice that cervical cancer vaccinations should no longer be recommended for girls aged 12 to 16 because several adverse reactions
Speaking out: Mika Matsufuji (center), who represents a parents’ association of cervical cancer vaccination victims, answers reporters’ questions Friday at the health ministry in Tokyo. | KYODO Kyodo Jun 15, 2013 Article history Online: Jun 15, 2013 Print: Jun 16,… Read More ›
Merck cholesterol drug fails; risks seen/ But yet approved in the European Union in since 2008
Thu, 20 Dec 2012 17:03 GMT Reuters * Cites increase in nonfatal side effects * Says it will not seek U.S. approval of high-profile drug * Failure is latest setback for HDL-raising drugs * Merck shares fall 2.5 percent (Adds… Read More ›
Engineering Evil 